Quality of life instruments in oncology

G Velikova, D Stark, P Selby - European Journal of Cancer, 1999 - Elsevier
The objective of this article is to aid clinicians in understanding the current state of the
development and application of quality of life (QOL) instruments as outcome measures in …

What has been learned from measuring health-related quality of life in clinical oncology

D Osoba - European journal of cancer, 1999 - Elsevier
The measurement of health-related quality of life (HRQL) in oncology clinical trials has come
of age. Most cooperative clinical trials groups as well as individual institutions have either …

Recommendations for evaluating the validity of quality of life claims for labeling and promotion

NK Leidy, DA Revicki, B Genesté - Value in Health, 1999 - Elsevier
The pharmaceutical industry, the medical device industry, and national regulatory agencies
such as the United States Food and Drug Administration (FDA) are faced with a number of …

Physical and psychological morbidity after axillary lymph node dissection for breast cancer

TF Hack, L Cohen, J Katz, LS Robson… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: Alternatives to axillary lymph node dissection (ALND) are being developed amid
controversy surrounding the therapeutic benefit and overall utility of this routine surgical …

[PDF][PDF] Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires

G Velikova, EP Wright, AB Smith, A Cull… - Journal of clinical …, 1999 - Citeseer
Purpose: To evaluate alternative automated methods of collecting data on quality of life
(QOL) in cancer patients. After initial evaluation of a range of technologies, we compared …

Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non–small-cell lung cancer: A randomized phase III study of the Italian Lung …

L Crino, GV Scagliotti, S Ricci, F De Marinis… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: To compare gemcitabine and cisplatin (GC) with mitomycin, ifosfamide, and
cisplatin (MIC) chemotherapy in patients with stage IIIB (limited to T4 for pleural effusion and …

A prospective study on quality of life of patients with cancer of the oral cavity or oropharynx treated with surgery with or without radiotherapy

A De Graeff, JRJ De Leeuw, WJG Ros, GJ Hordijk… - Oral oncology, 1999 - Elsevier
The aim of this study was to describe prospectively quality of life and mood in patients with
oral or oropharyngeal cancer treated with surgery±radiotherapy. Seventy-five patients …

Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses

KCA Sneeuw, NK Aaronson, MAG Sprangers… - British Journal of …, 1999 - nature.com
This study examined the usefulness of caregiver ratings of cancer patients' quality of life
(QOL), an issue of relevance to both adequate patient care and to the possible use of proxy …

[PDF][PDF] Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone

D Osoba, IF Tannock, DS Ernst, AJ Neville - Journal of Clinical Oncology, 1999 - Citeseer
Purpose: A combination of mitoxantrone plus prednisone is preferable to prednisone alone
for reduction of pain in men with metastatic, hormone-resistant, prostate cancer. The …

A prospective study on quality of life of laryngeal cancer patients treated with radiotherapy

A de Graeff, RJ de Leeuw, WJG Ros… - Head & Neck …, 1999 - Wiley Online Library
Background The aim of this study was to describe prospectively quality of life and mood
before and after radiotherapy for laryngeal cancer. Methods Sixty‐five patients with Tis‐T3 …